Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes it difficult to breathe. The main symptoms of COPD are shortness of breath, coughing, andwheezing. COPD is a leading cause of hospitalization in the United States. In fact, COPD was the third most common reason for hospitalization in 2010, accounting for nearly 1.5 million hospitalizations.1 COPD is also a major cause of death. In 2012, COPD was the fourth leading cause of death in the United States, killing more than 150,000 people.2 While there is no cure for COPD, there are treatments that can help improve symptoms and slow the progression of the disease. If you have COPD, it’s important to work with your doctor to create a treatment plan that is right for you.
Chronic respiratory disease is most commonly diagnosed in men and women of the same gender. Tobacco use is the most common risk factor for COPD, followed by exposure to air pollutants indoors and out, as well as previous infections. Every year, COPD patients experience one to four exacerbations, and one out of every six episodes results in admission to the hospital. More than one-third of COPD patients are readmitted within three months of discharge, with 7% dying within three months of discharge for COPD. The goal of this study was to determine the characteristics of COPD patients who require hospitalization and/or re-admission due to respiratory exacerbations. This study was approved by the Santiago-Lugo Research Ethics Committee in accordance with registry code 2016/196. The data was collected over a two-year period, so all data was sourced from electronic records without intervention or modification of the clinical course.
EHRs and different health information systems, as well as national health cards, were used to collect the data. Each COPD patient was individually assessed for a variety of factors, including smoking habits, comorbidity, anxiety, depression, dementia, and stroke risk. A CRG was calculated by an automatic grouper based on healthcare contact with primary care, hospitalization, and pharmaceutical prescriptions that had been recorded in the electronic health record. The data was analyzed using multinomial logistic regression models to determine predictors of respiratory-related admissions and re-admissions to the hospital. Over the course of 2016, COPD patients were identified in the EHRs of 8,861 people. Excluding 4,587 patients was the case in the majority of cases because they had not been to the spirometry lab in the previous three years. The following subjects were included in the 4,274-subject sample: 2,637 to the NF group, 1,140 to the MSD attendance group, and 497 to the ND group.
Male gender, age over 70 years, chronicmorbidity, a CHA2D-VASc scale score above 3, and absence of spirometric follow-up in primary care are all risk factors for re-admission in men. The following table provides a list of factors that contribute to COPD patients’ higher mortality rates. Those who were admitted to the hospital for the study period for at least one day required to be readmitted 55% of the time after being discharged. Men over the age of 70 and smokers are more likely to be admitted to the hospital due to respiratory problems. Home oxygen therapy was discovered to be the most reliable predictor of re-admission in COPD patients. According to our findings, 14.3% of hospitalized patients died, while 15.8% of patients who had relapsed died. Cerezo et al.
‘s study estimated these figures differently. It was discovered that frequent out-of-hospital attendance (primary care and CCPs) was related to mortality in a novel study. The study’s primary strength is the study’s ability to include the entire population of patients assigned to a specific health area. The researcher, in addition to eliminating bias due to insufficient intervention, implemented a uniform data collection system. Experts working together on health information systems can produce an excellent body of evidence. The work that was reported was made possible by the contributions of all authors, whether it was in the conception, study design, data acquisition, analysis, interpretation, or all of the above. The Santiago-Lugo Research Ethics Committee reviewed the study protocol and voted on it in accordance with registry code 2016/196.
There is no conflict of interest between the authors and the work they are publishing. Acute exacerbation following discharge from the hospital is linked to a subsequent progressive increase in mortality risk in COPD patients. For a 25-year period, 1990 to 2019, a total of 369 diseases and injuries were reported in 204 countries and territories worldwide, according to a study published in The Lancet. A Spanish study looked into the impact of co-morbidities on patients with COPD who were admitted to the hospital for respiratory problems.
Chronic obstructive pulmonary disease (COPD) patients who are hospitalized frequently do so due to a variety of factors, including pneumonia and infection. One of the most common causes is COPD exacerbation, which is defined as “a change in breathing symptoms that affects the normal daily pattern of breathing,” according to M.
Because of the increased length of stay and the high rate of readmissions, COPD health care costs continue to rise. An acute COPD exacerbation can last anywhere between 4.5 and 8.8 days on average.
We looked at hospitalization data for 33,558 COPD patients at 130 hospitals as part of our analysis. The average patient LOS was 3.99 days (standard deviation [SD] = 4.06).
